These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2938736)

  • 61. Enrichment of antitumor effector cells that are effective in vivo from spleen cells of tumor-bearing mice through the use of Dolichos biflorus lectin.
    Okada T; Ezawa K; Imai Y; Osawa T
    Cancer Res; 1986 Nov; 46(11):5611-7. PubMed ID: 3093067
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Highly malignant tumor variants retain tumor-specific antigens recognized by T helper cells.
    Van Waes C; Urban JL; Rothstein JL; Ward PL; Schreiber H
    J Exp Med; 1986 Nov; 164(5):1547-65. PubMed ID: 2945891
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self.
    Mizuochi T; Golding H; Rosenberg AS; Glimcher LH; Malek TR; Singer A
    J Exp Med; 1985 Aug; 162(2):427-43. PubMed ID: 3160804
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
    Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T
    J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selective expression of the Ly-6C.2 epitope on Lyt-2+ T cells that can develop in the absence of thymic influence.
    Leo O; Foo M; Forman J; Shivakumar S; Rabinowitz R; Bluestone JA
    J Immunol; 1988 Jul; 141(1):37-44. PubMed ID: 2454263
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of variant and parental-cross-protective immunity to immunogenic variants of a murine fibrosarcoma using the local adoptive transfer assay.
    Simcik W; Sheu TL; LeGrue SJ
    Cancer Immunol Immunother; 1989; 30(4):219-26. PubMed ID: 2598191
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
    Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
    J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer.
    Sakaguchi S; Takahashi T; Nishizuka Y
    J Exp Med; 1982 Dec; 156(6):1565-76. PubMed ID: 6983557
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system.
    Nash AA; Jayasuriya A; Phelan J; Cobbold SP; Waldmann H; Prospero T
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():825-33. PubMed ID: 2950204
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regulation of the cytotoxic activity of alloreactive cytotoxic T lymphocytes by helper cells and lymphokines.
    Ting CC; Loh NN; Hargrove ME
    Cell Immunol; 1986 Sep; 101(2):299-311. PubMed ID: 2944608
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The immunosuppressive effect of monoclonal anti-Lyt-1.1 antibodies in vivo.
    Michaelides M; Hogarth PM; McKenzie IF
    Eur J Immunol; 1981 Dec; 11(12):1005-12. PubMed ID: 6173235
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Frequency of cytotoxic T lymphocyte precursors to herpes simplex virus type 1 as determined by limiting dilution analysis.
    Rouse BT; Larsen HS; Wagner H
    Infect Immun; 1983 Feb; 39(2):785-92. PubMed ID: 6299949
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of interleukin 2-producing T helper cells within murine Lyt-2+ T lymphocytes: frequency, specificity and clonal segregation from Lyt-2+ precursors of cytotoxic T lymphocytes.
    Heeg K; Steeg C; Hardt C; Wagner H
    Eur J Immunol; 1987 Feb; 17(2):229-36. PubMed ID: 2951263
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Augmentation of the generation of cytotoxic T lymphocytes against syngeneic tumor cells by recombinant human tumor necrosis factor.
    Nakano K; Okugawa K; Furuichi H; Matsui Y; Sohmura Y
    Cell Immunol; 1989 Apr; 120(1):154-64. PubMed ID: 2649256
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Suppression of the generation of secondary virus-specific proliferative and cytotoxic T lymphocytes by suppressor cells induced during primary anti-viral sensitization in vitro.
    Kreeb G; Creighton WD; Zinkernagel RM
    Immunology; 1981 May; 43(1):47-55. PubMed ID: 6454648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants.
    Bianchi R; Fioretti MC; Grohmann U; Binaglia L; Romani L; Puccetti P
    Int J Immunopharmacol; 1992 Jul; 14(5):915-21. PubMed ID: 1512082
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL; Fitch FW
    J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of T cell subsets in the generation of secondary cytolytic responses in vitro against class I and class II major histocompatibility complex antigens.
    Vidović D; Klein J; Nagy ZA
    J Immunol; 1984 Mar; 132(3):1113-7. PubMed ID: 6229577
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.